MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...
HONOLULU (KHON2) — With the New Year quickly coming up, fire departments across the islands are urging those celebrating to ensure that they safely and legally enjoy their fireworks. Permits are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback